Many Patients Stop GLP-1 Treatments Early
Study finds many patients pause GLP-1 drugs before eventually restarting treatment.
Sara is a credited writer, editor, contributor, and essayist, as well as a novelist and poet with more than two decades of experience in media arts. A seasoned publishing professional, she's worked for newspapers, magazines and book publishers in content digitization, editorial, acquisitions and intellectual property. Sara is a member of the International Association of Writers & Editors, has received numerous awards and has been an invited speaker at a Careers in Publishing & Authorship event at Michigan State University and a Reading and Writing Instructor at Sylvan Learning Center. She is also a mental health therapist, clinical supervisor and entrepreneur, holding an MBA degree with a concentration in Marketing and an MA in Clinical Mental Health Counseling (graduating with a 4.2/4.0 GPA). Additionally, she is a member of Chi Sigma Iota, was on her local chapter's board, and a 2020 recipient of the Donald D. Davis scholarship recognizing social responsibility. Sara is certified in children's book writing, HTML coding and social media marketing. Her nine books can be found on Amazon.
Study finds many patients pause GLP-1 drugs before eventually restarting treatment.
Cornell student faces backlash after rejecting job offer with antisemitic message and comments.
Albuquerque man faces federal charge after alleged attacks on synagogue and Jewish community center.
Scientists begin first human trial testing whether aging cells can regain youthful function safely.
Papa Johns cuts locations as pizza sales decline across markets.
Federal case alleges child smuggling, fraud, and exploitation scheme.
Officials warn families about dangers linked to common allergy medications.
Settlement resolves lawsuit tied to Dakota Access Pipeline protest response.
Officials investigate fatal listeria outbreak connected to recalled cheese products.
Texas couple received prison sentences for massive pandemic-era fraud.